speb/financial-data huggingface dataset:
SRZN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 16043000.00
SRZN cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 113000.00
SRZN income_statement (annual, 2024-12-31) — Net Income: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -63564000.00
SRZN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -63564000.00
SRZN income_statement (annual, 2024-12-31) — Net Interest Income: 1693000.00
SRZN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
SRZN cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
SRZN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1693000.00
SRZN balance_sheet (annual, 2024-12-31) — Net PPE: 8363000.00
SRZN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -26000.00
SRZN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -21380000.00
SRZN income_statement (annual, 2024-12-31) — Normalized EBITDA: -24097000.00
SRZN income_statement (annual, 2024-12-31) — Normalized Income: -63564000.00
SRZN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -17628000.00
SRZN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 39847000.00
SRZN income_statement (annual, 2024-12-31) — Operating Income: -25539000.00
SRZN income_statement (annual, 2024-12-31) — Operating Revenue: 10655000.00
SRZN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 3262000.00
SRZN balance_sheet (annual, 2024-12-31) — Other Current Assets: 671000.00
SRZN balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 671000.00
SRZN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 191000.00
SRZN income_statement (annual, 2024-12-31) — Other Gand A: 15062000.00
SRZN income_statement (annual, 2024-12-31) — Other Income Expense: -39718000.00
SRZN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1369000.00
SRZN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1019000.00
SRZN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -39718000.00
SRZN balance_sheet (annual, 2024-12-31) — Other Properties: 14578000.00
SRZN balance_sheet (annual, 2024-12-31) — Payables: 306000.00
SRZN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5295000.00
SRZN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
SRZN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1826000.00
SRZN balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1826000.00
SRZN income_statement (annual, 2024-12-31) — Pretax Income: -63564000.00
SRZN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 133000.00
SRZN balance_sheet (annual, 2024-12-31) — Properties: 0.00
SRZN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
SRZN cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
SRZN cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
SRZN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -26000.00
SRZN balance_sheet (annual, 2024-12-31) — Receivables: 2541000.00
SRZN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1442000.00
SRZN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
SRZN income_statement (annual, 2024-12-31) — Research And Development: 21132000.00
SRZN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
SRZN income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
SRZN balance_sheet (annual, 2024-12-31) — Retained Earnings: -285259000.00
SRZN cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
SRZN cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
SRZN income_statement (annual, 2024-12-31) — Selling General And Administration: 15062000.00
SRZN balance_sheet (annual, 2024-12-31) — Share Issued: 3262000.00
SRZN income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
SRZN income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
SRZN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4114000.00
SRZN balance_sheet (annual, 2024-12-31) — Stockholders Equity: -21380000.00
SRZN balance_sheet (annual, 2024-12-31) — Tangible Book Value: -21380000.00
SRZN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SRZN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
SRZN balance_sheet (annual, 2024-12-31) — Total Assets: 48467000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Capitalization: -21380000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Debt: 8469000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -21380000.00
SRZN income_statement (annual, 2024-12-31) — Total Expenses: 36194000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 69847000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 9535000.00
SRZN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 62532000.00
SRZN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -25539000.00
SRZN income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
SRZN income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
SRZN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SRZN income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
SRZN balance_sheet (annual, 2024-12-31) — Working Capital: 31617000.00
SRZN income_statement (quarterly, 2025-03-31) — +Operating Expense: 10534000.00
SRZN income_statement (quarterly, 2025-03-31) — +Total Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 302000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2130000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 317902000.00
SRZN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3628000.00
SRZN income_statement (quarterly, 2025-03-31) — Basic EPS: -7.43
SRZN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 35253000.00
SRZN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -27000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7968000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 101645000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 101645000.00
SRZN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 76386000.00
SRZN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -27000.00
SRZN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -9279000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -1193000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 17000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -501000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Payable: -4000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1197000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 305000.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
SRZN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1376000.00
SRZN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
SRZN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 67080000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5674000.00
SRZN cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 76386000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 8837000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Current Assets: 106011000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1190000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1190000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 10582000.00
SRZN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 294000.00
SRZN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 294000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 49372000.00
SRZN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3628000.00
SRZN income_statement (quarterly, 2025-03-31) — Diluted EPS: -7.43
SRZN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -26970000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 502000.00
SRZN income_statement (quarterly, 2025-03-31) — EBIT: -9551000.00
SRZN income_statement (quarterly, 2025-03-31) — EBITDA: -9257000.00
SRZN cash_flow (quarterly, 2025-03-31) — End Cash Position: 102333000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Financial Assets: 384000.00
SRZN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 76386000.00
SRZN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -9306000.00
SRZN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -53274000.00
SRZN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -2073000.00
SRZN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3976000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 7645000.00
SRZN income_statement (quarterly, 2025-03-31) — Interest Income: 296000.00
SRZN income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 296000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5674000.00
SRZN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -27000.00
SRZN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 76386000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 6778000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 6778000.00
SRZN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 76386000.00
SRZN cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -91000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -26970000.00
SRZN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -26970000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Interest Income: 296000.00
SRZN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 296000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Net PPE: 7645000.00
SRZN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -27000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5674000.00
SRZN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7184000.00
SRZN income_statement (quarterly, 2025-03-31) — Normalized Income: -24897000.00
SRZN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -9279000.00
SRZN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -53365000.00
SRZN income_statement (quarterly, 2025-03-31) — Operating Income: -9551000.00
SRZN income_statement (quarterly, 2025-03-31) — Operating Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 8494584.00
SRZN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1734000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 253000.00
SRZN income_statement (quarterly, 2025-03-31) — Other Gand A: 3976000.00
SRZN income_statement (quarterly, 2025-03-31) — Other Income Expense: -17715000.00
SRZN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 71304000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 789000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 42423000.00
SRZN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -15642000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Other Properties: 7645000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Payables: 302000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 9139000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
SRZN income_statement (quarterly, 2025-03-31) — Pretax Income: -26970000.00
SRZN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
SRZN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -27000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Receivables: 2632000.00
SRZN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 294000.00
SRZN income_statement (quarterly, 2025-03-31) — Research And Development: 6558000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -312229000.00
SRZN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3976000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Share Issued: 8494584.00
SRZN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 834000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5674000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5674000.00
SRZN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SRZN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Assets: 114829000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5674000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Debt: 7968000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5674000.00
SRZN income_statement (quarterly, 2025-03-31) — Total Expenses: 10534000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 109155000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8818000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 98573000.00
SRZN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -9551000.00
SRZN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -2073000.00
SRZN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -2073000.00
SRZN balance_sheet (quarterly, 2025-03-31) — Working Capital: 95429000.00
SRZN income_statement (quarterly, 2025-06-30) — +Operating Expense: 10000000.00
SRZN income_statement (quarterly, 2025-06-30) — +Total Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 354000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2317000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 319596000.00
SRZN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 8541000.00
SRZN income_statement (quarterly, 2025-06-30) — Basic EPS: 2.55
SRZN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 102333000.00
SRZN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -18000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7514000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 90390000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 90390000.00
SRZN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -5124000.00
SRZN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -18000.00
SRZN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -6113000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 52000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 204000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 19000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -454000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Payable: 52000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 256000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 458000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 250000.00
SRZN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 529000.00
SRZN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 250000.00
SRZN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -11255000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 47114000.00
SRZN cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -5185000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3959000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Current Assets: 94235000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1198000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1198000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5743000.00
SRZN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 137000.00
SRZN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 137000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 32620000.00
SRZN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 8541000.00
SRZN income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.55
SRZN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 21808000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 252000.00
SRZN income_statement (quarterly, 2025-06-30) — EBIT: -9017000.00
SRZN income_statement (quarterly, 2025-06-30) — EBITDA: -8880000.00
SRZN cash_flow (quarterly, 2025-06-30) — End Cash Position: 91078000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Financial Assets: 615000.00
SRZN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -5124000.00
SRZN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -6131000.00
SRZN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -47551000.00
SRZN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 31520000.00
SRZN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3958000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7076000.00
SRZN income_statement (quarterly, 2025-06-30) — Interest Income: 1025000.00
SRZN income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1025000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 47114000.00
SRZN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -18000.00
SRZN cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -5185000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6316000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6316000.00
SRZN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -5185000.00
SRZN cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -187000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income: 39746000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 21808000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 39746000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 39746000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 39746000.00
SRZN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 39746000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 39746000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Interest Income: 1025000.00
SRZN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1025000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Net PPE: 7076000.00
SRZN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -18000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 47114000.00
SRZN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -40400000.00
SRZN income_statement (quarterly, 2025-06-30) — Normalized Income: 14845200.00
SRZN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6113000.00
SRZN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -47738000.00
SRZN income_statement (quarterly, 2025-06-30) — Operating Income: -9017000.00
SRZN income_statement (quarterly, 2025-06-30) — Operating Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 8570355.00
SRZN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 232000.00
SRZN income_statement (quarterly, 2025-06-30) — Other Gand A: 3958000.00
SRZN income_statement (quarterly, 2025-06-30) — Other Income Expense: 47738000.00
SRZN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 219000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 770000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 10903000.00
SRZN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 16218000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Other Properties: 7076000.00
SRZN income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 17938000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Payables: 354000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4313000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
SRZN balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1276000.00
SRZN income_statement (quarterly, 2025-06-30) — Pretax Income: 39746000.00
SRZN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 61000.00
SRZN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -18000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Receivables: 2569000.00
SRZN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 137000.00
SRZN income_statement (quarterly, 2025-06-30) — Research And Development: 6042000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -272483000.00
SRZN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3958000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Share Issued: 8570355.00
SRZN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 994000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 47114000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 47114000.00
SRZN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 6619200.00
SRZN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
SRZN balance_sheet (quarterly, 2025-06-30) — Total Assets: 102696000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 47114000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Debt: 7514000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 47114000.00
SRZN income_statement (quarterly, 2025-06-30) — Total Expenses: 10000000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 55582000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 8461000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 49839000.00
SRZN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -9017000.00
SRZN income_statement (quarterly, 2025-06-30) — Total Unusual Items: 31520000.00
SRZN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 31520000.00
SRZN balance_sheet (quarterly, 2025-06-30) — Working Capital: 88492000.00
SRZN income_statement (quarterly, 2025-09-30) — +Operating Expense: 11868000.00
SRZN income_statement (quarterly, 2025-09-30) — +Total Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 538000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2317000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 320610000.00
SRZN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 8571000.00
SRZN income_statement (quarterly, 2025-09-30) — Basic EPS: -8.36
SRZN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 91078000.00
SRZN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -24000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7082000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 81335000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 81335000.00
SRZN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 9000.00
SRZN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -24000.00
SRZN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -9040000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 184000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 555000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 18000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -432000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Payable: 184000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 739000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -681000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1000.00
SRZN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -355000.00
SRZN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1000.00
SRZN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -9055000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -23515000.00
SRZN cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
SRZN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4455000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Current Assets: 85860000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1244000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1244000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6528000.00
SRZN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 61000.00
SRZN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 61000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 53544000.00
SRZN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 8571000.00
SRZN income_statement (quarterly, 2025-09-30) — Diluted EPS: -8.36
SRZN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -71643000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 251000.00
SRZN income_statement (quarterly, 2025-09-30) — EBIT: -10885000.00
SRZN income_statement (quarterly, 2025-09-30) — EBITDA: -10824000.00
SRZN cash_flow (quarterly, 2025-09-30) — End Cash Position: 82023000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Financial Assets: 845000.00
SRZN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 9000.00
SRZN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -9064000.00
SRZN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 61672000.00
SRZN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -40748000.00
SRZN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4094000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6589000.00
SRZN income_statement (quarterly, 2025-09-30) — Interest Income: 911000.00
SRZN income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 911000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Invested Capital: -23515000.00
SRZN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -24000.00
SRZN cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
SRZN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5838000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5838000.00
SRZN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
SRZN cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 0.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -71643000.00
SRZN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -71643000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Interest Income: 911000.00
SRZN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 911000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Net PPE: 6589000.00
SRZN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -24000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -23515000.00
SRZN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 29924000.00
SRZN income_statement (quarterly, 2025-09-30) — Normalized Income: -30895000.00
SRZN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -9040000.00
SRZN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 61672000.00
SRZN income_statement (quarterly, 2025-09-30) — Operating Income: -10885000.00
SRZN income_statement (quarterly, 2025-09-30) — Operating Revenue: 983000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 8571000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 291000.00
SRZN income_statement (quarterly, 2025-09-30) — Other Gand A: 4094000.00
SRZN income_statement (quarterly, 2025-09-30) — Other Income Expense: -61669000.00
SRZN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 220000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 752000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 51651000.00
SRZN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -20921000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Other Properties: 6589000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Payables: 538000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 4993000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
SRZN balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1957000.00
SRZN income_statement (quarterly, 2025-09-30) — Pretax Income: -71643000.00
SRZN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 9000.00
SRZN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -24000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Receivables: 2568000.00
SRZN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 61000.00
SRZN income_statement (quarterly, 2025-09-30) — Research And Development: 7774000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -344126000.00
SRZN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4094000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Share Issued: 8571000.00
SRZN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1005000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -23515000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -23515000.00
SRZN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SRZN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Assets: 94046000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -23515000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Debt: 7082000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -23515000.00
SRZN income_statement (quarterly, 2025-09-30) — Total Expenses: 11868000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 117561000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 8186000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 111033000.00
SRZN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -10885000.00
SRZN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -40748000.00
SRZN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -40748000.00
SRZN balance_sheet (quarterly, 2025-09-30) — Working Capital: 79332000.00
SRZN income_statement (annual, 2025-12-31) — +Operating Expense: 45569000.00
SRZN income_statement (quarterly, 2025-12-31) — +Operating Expense: 13167000.00
SRZN income_statement (annual, 2025-12-31) — +Total Revenue: 3477000.00
SRZN income_statement (quarterly, 2025-12-31) — +Total Revenue: 528000.00
SRZN balance_sheet (annual, 2025-12-31) — Accounts Payable: 728000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 728000.00
SRZN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 0.00
SRZN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 0.00
SRZN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -8375000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -8375000.00
SRZN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 339522000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 339522000.00
SRZN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 922000.00
SRZN income_statement (annual, 2025-12-31) — Basic Average Shares: 7478000.00
SRZN income_statement (annual, 2025-12-31) — Basic EPS: -32.37
SRZN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 35253000.00
SRZN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 82023000.00
SRZN cash_flow (annual, 2025-12-31) — Capital Expenditure: -128000.00
SRZN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -59000.00
SRZN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6639000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6639000.00
SRZN balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
SRZN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 89245000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 89245000.00
SRZN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 89245000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 89245000.00
SRZN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 85052000.00
SRZN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 13781000.00
SRZN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -128000.00
SRZN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -59000.00
SRZN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -30244000.00
SRZN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5812000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Account Payable: 142000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -90000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2503000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 2937000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 72000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 18000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1830000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -443000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Payable: 142000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Payable: -90000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2645000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2847000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -67000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -149000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Receivables: 2333000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2082000.00
SRZN cash_flow (annual, 2025-12-31) — Change In Working Capital: 3153000.00
SRZN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4355000.00
SRZN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 2333000.00
SRZN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 2082000.00
SRZN cash_flow (annual, 2025-12-31) — Changes In Cash: 54680000.00
SRZN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 7910000.00
SRZN balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
SRZN balance_sheet (annual, 2025-12-31) — Common Stock Equity: -187762000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -187762000.00
SRZN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 83780000.00
SRZN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 12579000.00
SRZN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7623000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7623000.00
SRZN balance_sheet (annual, 2025-12-31) — Current Assets: 91559000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Current Assets: 91559000.00
SRZN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1290000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1290000.00
SRZN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1290000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1290000.00
SRZN balance_sheet (annual, 2025-12-31) — Current Liabilities: 9930000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9930000.00
SRZN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 537000.00
SRZN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 45000.00
SRZN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 537000.00
SRZN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 45000.00
SRZN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 112547000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 112547000.00
SRZN income_statement (annual, 2025-12-31) — Diluted Average Shares: 7478000.00
SRZN income_statement (annual, 2025-12-31) — Diluted EPS: -32.37
SRZN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -183159000.00
SRZN balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 208000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 208000.00
SRZN income_statement (annual, 2025-12-31) — EBIT: -42092000.00
SRZN income_statement (quarterly, 2025-12-31) — EBIT: -12639000.00
SRZN income_statement (annual, 2025-12-31) — EBITDA: -41555000.00
SRZN income_statement (quarterly, 2025-12-31) — EBITDA: -12594000.00
SRZN cash_flow (annual, 2025-12-31) — End Cash Position: 89933000.00
SRZN cash_flow (quarterly, 2025-12-31) — End Cash Position: 89933000.00
SRZN balance_sheet (annual, 2025-12-31) — Financial Assets: 0.00
SRZN balance_sheet (quarterly, 2025-12-31) — Financial Assets: 0.00
SRZN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 85052000.00
SRZN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 13781000.00
SRZN cash_flow (annual, 2025-12-31) — Free Cash Flow: -30372000.00
SRZN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -5871000.00
SRZN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 131219000.00
SRZN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 170372000.00
SRZN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -176642000.00
SRZN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -111714000.00
SRZN income_statement (annual, 2025-12-31) — General And Administrative Expense: 16204000.00
SRZN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4176000.00
SRZN balance_sheet (annual, 2025-12-31) — Gross PPE: 14808000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14808000.00
SRZN income_statement (annual, 2025-12-31) — Interest Income: 3020000.00
SRZN income_statement (quarterly, 2025-12-31) — Interest Income: 788000.00
SRZN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3020000.00
SRZN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 788000.00
SRZN balance_sheet (annual, 2025-12-31) — Invested Capital: -187762000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Invested Capital: -187762000.00
SRZN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -128000.00
SRZN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -59000.00
SRZN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 83780000.00
SRZN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 12579000.00
SRZN balance_sheet (annual, 2025-12-31) — Leases: 1116000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Leases: 1116000.00
SRZN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 5349000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 5349000.00
SRZN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5349000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5349000.00
SRZN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 516000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 516000.00
SRZN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 83780000.00
SRZN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 12579000.00
SRZN cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
SRZN cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 278000.00
SRZN income_statement (annual, 2025-12-31) — Net Income: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -183159000.00
SRZN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -242026000.00
SRZN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -242026000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -183159000.00
SRZN income_statement (annual, 2025-12-31) — Net Interest Income: 3020000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Interest Income: 788000.00
SRZN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3020000.00
SRZN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 788000.00
SRZN balance_sheet (annual, 2025-12-31) — Net PPE: 6433000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Net PPE: 6433000.00
SRZN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -128000.00
SRZN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -59000.00
SRZN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -187762000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -187762000.00
SRZN income_statement (annual, 2025-12-31) — Normalized EBITDA: 135087000.00
SRZN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 99120000.00
SRZN income_statement (annual, 2025-12-31) — Normalized Income: -65384000.00
SRZN income_statement (quarterly, 2025-12-31) — Normalized Income: -71445000.00
SRZN cash_flow (annual, 2025-12-31) — Operating Cash Flow: -30244000.00
SRZN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -5812000.00
SRZN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 131219000.00
SRZN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 170650000.00
SRZN income_statement (annual, 2025-12-31) — Operating Income: -42092000.00
SRZN income_statement (quarterly, 2025-12-31) — Operating Income: -12639000.00
SRZN income_statement (annual, 2025-12-31) — Operating Revenue: 3477000.00
SRZN income_statement (quarterly, 2025-12-31) — Operating Revenue: 528000.00
SRZN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 9774537.00
SRZN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 9774537.00
SRZN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 289000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 289000.00
SRZN income_statement (annual, 2025-12-31) — Other Gand A: 16204000.00
SRZN income_statement (quarterly, 2025-12-31) — Other Gand A: 4176000.00
SRZN income_statement (annual, 2025-12-31) — Other Income Expense: -202954000.00
SRZN income_statement (quarterly, 2025-12-31) — Other Income Expense: -171308000.00
SRZN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 72116000.00
SRZN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 373000.00
SRZN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 734000.00
SRZN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 734000.00